Do Increased Levels of Soluble Fas Correlate with Disease Activity in Systemic Lupus Erythematosus / 대한류마티스학회지
The Journal of the Korean Rheumatism Association
;
: 16-22, 2003.
Article
in Korean
| WPRIM
| ID: wpr-168284
ABSTRACT
OBJECTIVE:
To determine whether levels of soluble Fas (sFas) are elevated in patients with systemic lupus erythematosus (SLE) and correlated with clinical disease activity.METHODS:
Serum samples were obtained from 62 SLE patients and 39 normal controls. We measured sFas levels using an enzyme-linked immunosorbent assay. Disease activity variables including Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) were examined.RESULTS:
The mean age of the patients was 32.1 years (range 13~60 years) and the mean disease duration was 3.0 years (range 0.2~10.0 years); 1 patient was male (1.6%). The median serum sFas concentration was 610.0 pg/ml for SLE patients and 292.9 pg/ml in controls. The serum sFas concentration was significantly higher in SLE patients than in controls (p or =8) and inactive (SLEDAI <8) SLE patients.CONCLUSION:
These results suggest that sFas levels are elevated in SLE patients, but sFas does not reflect disease activity.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Complement System Proteins
/
Enzyme-Linked Immunosorbent Assay
/
ROC Curve
/
Sensitivity and Specificity
/
Lupus Erythematosus, Systemic
/
Antibodies
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
/
Male
Language:
Korean
Journal:
The Journal of the Korean Rheumatism Association
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS